Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -170055.93% is 22096% below its 5-year average of -766.17%, near the low end of its 5-year range (-170055.93%–9251.81%).
3556.45% below its 12-month average of -4650.85%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
-170055.93%
NET PROFIT MARGIN AVG TTM
-4650.85%
NET PROFIT MARGIN AVG 3Y
-491.99%
NET PROFIT MARGIN AVG 5Y
-766.17%
NET PROFIT MARGIN AVG 10Y
-650.30%
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-3556.45%
CURRENT VS 3Y AVG
-34464.84%
CURRENT VS 5Y AVG
-22095.60%
CURRENT VS 10Y AVG
-26050.54%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 787 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Avalo Therapeutics, Inc.
Market Cap
$701.75M
Net Profit Margin
-170055.93%
TTM Avg
-4650.85%
3Y Avg
-491.99%
5Y Avg
-766.17%
Market Cap
$706.51M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$714.67M
Net Profit Margin
5.93%
TTM Avg
9.51%
3Y Avg
5.53%
5Y Avg
9.43%
Market Cap
$693.75M
Net Profit Margin
-4619.67%
TTM Avg
-3871.87%
3Y Avg
-2595.36%
5Y Avg
-1815.29%
Market Cap
$718.68M
Net Profit Margin
-38.98%
TTM Avg
-18.01%
3Y Avg
-10.19%
5Y Avg
-2.91%
Market Cap
$727.50M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$682.75M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-265.57%
5Y Avg
-265.38%
Market Cap
$730.28M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | $701.75M | -170055.93% | -4650.85% | -491.99% | -766.17% |
| Olema Pharmaceuticals, Inc. (OLMA)vs › | $706.51M | 0.00% | 0.00% | 0.00% | 0.00% |
| Collegium Pharmaceutical, Inc. (COLL)vs › | $714.67M | 5.93% | 9.51% | 5.53% | 9.43% |
| Anteris Technologies Global Corp. (AVR)vs › | $693.75M | -4619.67% | -3871.87% | -2595.36% | -1815.29% |
| Cytek Biosciences, Inc. (CTKB)vs › | $718.68M | -38.98% | -18.01% | -10.19% | -2.91% |
| ArriVent BioPharma, Inc. (AVBP)vs › | $727.50M | 0.00% | 0.00% | 0.00% | 0.00% |
| Solid Biosciences Inc. (SLDB)vs › | $682.75M | 0.00% | 0.00% | -265.57% | -265.38% |
| Achieve Life Sciences, Inc. (ACHV)vs › | $730.28M | 0.00% | 0.00% | 0.00% | 0.00% |
| Annexon, Inc. (ANNX)vs › | $674.21M | 0.00% | 0.00% | 0.00% | 0.00% |
| Helus Pharma Inc. (HELP)vs › | $671.91M | 329.09% | -11813.45% | -10636.53% | -14431.57% |
Operating Margin
-123601.7%
Net Profit Margin
-170055.9%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | -23254.24% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | -18405.73% |
| 2024-09-30 | 9251.81% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | -1430.47% |
| 2023-09-30 | -2215.25% |
| 2023-06-30 | -1274.18% |
| 2023-03-31 | -2095.79% |
| 2022-12-31 | -1095.09% |
| 2022-09-30 | 21.35% |
| 2022-06-30 | -1257.21% |
| 2022-03-31 | -1879.88% |
| 2021-12-31 | -8765.30% |
| 2021-09-30 | -1288.52% |
| 2021-06-30 | -509.84% |
| 2021-03-31 | -6486.26% |
| 2020-12-31 | -1044.96% |
| 2020-09-30 | -1211.43% |
| 2020-06-30 | -992.60% |
| 2020-03-31 | -766.78% |
| 2019-12-31 | -18.58% |
| 2019-09-30 | -71.55% |
| 2019-06-30 | -139.86% |
| 2019-03-31 | -137.75% |
| 2018-12-31 | -111.53% |
| 2018-09-30 | -603.80% |
| 2018-06-30 | -125.54% |
| 2018-03-31 | -86.62% |
| 2017-12-31 | -138.42% |
| 2017-09-30 | 74.77% |
| 2017-06-30 | -1139.74% |
| 2017-03-31 | -510.31% |
| 2016-12-31 | -900.55% |
| 2016-09-30 | -1918.75% |
| 2016-06-30 | -541.77% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | -21.80% |
| 2012-12-31 | 0.00% |
